Impact of pancreatic cancer and subsequent resection on glycemic control in diabetic and nondiabetic patients

American Surgeon

Volumn 77, Issue 8, 2011, Pages 1032-1037

  White, Michael A ^a   Agle, Steven C ^a   Fuhr, Hannah M ^a   Mehaffey, James H ^a   Waibel, Brett H ^a   Zervos, Emmanuel E ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; METFORMIN;

ABDOMINAL ABSCESS; ADULT; ARTICLE; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DELAYED GASTRIC EMPTYING; DIABETES MELLITUS; DISEASE EXACERBATION; ENTEROCUTANEOUS FISTULA; FEMALE; GASTRIC DYSMOTILITY; GLYCEMIC CONTROL; HEART ARRHYTHMIA; HEART INFARCTION; HUMAN; INCIDENCE; INTESTINE ISCHEMIA; KIDNEY FAILURE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PANCREAS FISTULA; PANCREAS ISLET CELL; PANCREAS RESECTION; PANCREATICODUODENECTOMY; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PREDICTION; PREOPERATIVE EVALUATION; RESPIRATORY FAILURE; RURAL AREA; SEPSIS; TREATMENT OUTCOME; UNIVARIATE ANALYSIS; UNIVERSITY HOSPITAL;

AGED; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; COHORT STUDIES; CONFIDENCE INTERVALS; DIABETES MELLITUS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HOSPITALS, UNIVERSITY; HUMANS; HYPOGLYCEMIC AGENTS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PANCREATECTOMY; PANCREATIC NEOPLASMS; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 80052044405     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Chari ST, Leibson CL, Rabe KG, et al. Pancreatic cancer- Associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology 2008;134:95-101. (Pubitemid 350309328)
2. Pannala R, Basu A, Petersen GM, Chari ST. New- Onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol 2009;10:88-95.
3. Wang F, Herrington M, Larsson J, Permert J. The relationship between diabetes and pancreatic cancer. Mol Cancer 2003;2:4.
4. Chu CK, Mazo AE, Sarmiento JM, et al. Impact of diabetes mellitus on perioperative outcomes after resection for pancreatic adenocarcinoma. J Am Coll Surg 2010;210:463-73.
5. Huxley R, Ansary-Moghaddam A, Berrington de Gonzalez A, et al. Type- II diabetes and pancreatic cancer: a meta- II diabetes and pancreatic cancer: a metaAnalysis of 36 studies. Br J Cancer 2005;92:2076-83. (Pubitemid 40897433)
6. Pfeffer F, Nauck MA, Benz S, Hopt UT. Secondary diabetes in pancreatic carcinoma and after pancreatectomy: Pathophysiology, therapeutic peculiarities and prognosis. Z Gastroenterol 1999;Suppl 1:10-4 [in German]. (Pubitemid 29344256)
7. King J, Kazanjian K, Matsumoto J, et al. Distal pancreatectomy: Incidence of postoperative diabetes. J Gastrointest Surg 2008;12:1548-53.
8. Hamilton L, Jeyarajah DR. Hemoglobin A1c can be helpful in predicting progression to diabetes after Whipple procedure. HPB (Oxford) 2007;9:26-8. (Pubitemid 46992938)
9. Permert J, Ihse I, Jorfeldt L, et al. Improved glucose metabolism after subtotal pancreatectomy for pancreatic cancer. Br J Surg 1993;80:1047-50. (Pubitemid 23261595)
10. Fogar P, Pasquali C, Basso D, et al. Diabetes mellitus in pancreatic cancer follow-Up. Anticancer Res 1994;14:2827-30.
11. Saruc M, Karaarslan M, Rasa K, et al. Pancreatic cancer and glucose metabolism. Turk J Gastroenterol 2009;20:257-60.
12. Litwin J, Dobrowolski S, Orlowska-Kunikowska E, Sledzinski Z. Changes in glucose metabolism after Kausch- Whipple pancreatectomy in pancreatic cancer and chronic pancreatitis patients. Pancreas 2008;36:26-30.
13. Pannala R, Leibson CL, Rabe KG, et al. Temporal association of changes in fasting Blood glucose and body mass index with diagnosis of pancreatic cancer. Am J Gastroenterol 2009;104:2318-25.
14. DiNorcia J, Ahmed L, Lee MK, et al. Better preservation of endocrine function after Central versus distal pancreatectomy for mid- Gland lesions. Surgery 2010;148:1247-54, discussion 1254-6.
15. Allendorf JD, Schrope BA, Lauerman MH, et al. Post- operative glycemic control after central pancreatectomy for midgland lesions. World J Surg 2007;31:164-8, discussion 169-70.
16. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987;40:373-83. (Pubitemid 17055592)
17. Permert J, Larsson J, Fruin AB, et al. Islet hormone secretion in pancreatic cancer patients with diabetes. Pancreas 1997;15:60-8. (Pubitemid 27527361)
18. Bakkevold KE, Kambestad B. Morbidity and mortality after radical and palliative pancreatic cancer surgery. Risk factors influencing the short- Term results. Ann Surg 1993;217:356-68. (Pubitemid 23115339)
19. Zervos EE, Agle SC, Warren AJ, et al. Amelioration of insulin requirement in patients undergoing duodenal bypass for reasons other than obesity implicates foregut factors in the pathophysiology of type II diabetes. J Am Coll Surg 2010;210:564-72, 572-4.